Should a 13-year-old receive a second dose of varicella vaccine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Should a 13-Year-Old Receive a Second Dose of Varicella Vaccine?

Yes, a 13-year-old without evidence of varicella immunity should absolutely receive a second dose of varicella vaccine if they have only received one prior dose. 1

Vaccination Requirements for Adolescents Aged ≥13 Years

All persons aged ≥13 years without evidence of varicella immunity must receive two 0.5-mL doses of single-antigen varicella vaccine administered subcutaneously, 4-8 weeks apart. 1

Key Points for This Age Group:

  • The minimum interval between doses for persons aged ≥13 years is 4 weeks (not 3 months as in younger children). 1

  • Only single-antigen varicella vaccine may be used for vaccination of persons in this age group—MMRV is not licensed for use among persons aged ≥13 years. 1

  • If more than 8 weeks elapse after the first dose, the second dose may be administered without restarting the schedule. 1

Rationale for Second Dose in Adolescents

Enhanced Protection

  • Two-dose vaccination provides 98.3% effectiveness compared to one dose alone. 2

  • The odds of developing varicella are 95% lower for children who received 2 doses compared with 1 dose. 2

  • One dose of varicella vaccine does not provide sufficient herd immunity to prevent outbreaks in school settings, where exposure can be intense and transmission among vaccinated persons is effective. 3

Special Considerations for Adolescents

  • Adolescents are at higher risk for severe chickenpox and complications compared to younger children, including higher rates of pneumonia and disseminated disease. 4

  • All students should be assessed for varicella immunity, and those without evidence of immunity should routinely receive 2 doses of single-antigen varicella vaccine 4-8 weeks apart. 1

  • The risk for transmission of varicella among school-aged children, college students, and students in other postsecondary educational institutions can be high because of high contact rates. 1

Catch-Up Vaccination Protocol

Second dose catch-up varicella vaccination is specifically recommended for children, adolescents, and adults who previously received 1 dose. 1

  • The recommended minimum interval between the first dose and the catch-up second dose is 4 weeks for persons aged ≥13 years. 1

  • The catch-up second dose may be administered at any interval longer than the minimum recommended interval. 1

  • Catch-up vaccination may be implemented during routine health-care provider visits and through school- and college-entry requirements. 1

Clinical Evidence Supporting Two-Dose Regimen

Effectiveness Data

  • The incremental vaccine effectiveness of 2-dose vaccination was 79% in randomized controlled trials, 63% in cohort studies, and 81% in case-control studies. 5

  • In outbreak settings with 99% vaccination coverage, one-dose vaccination was not sufficient to prevent transmission, with vaccine effectiveness against varicella of any severity at 82% and 97% for moderate/severe varicella. 3

Immunogenicity

  • Two-dose vaccination resulted in significantly higher geometric mean titers and seroconversion rates compared to one dose. 5

  • 99% of children receiving 2 doses achieved protective antibody levels compared with 86% of children who received 1 dose. 3

Common Pitfalls to Avoid

  • Do not delay the second dose beyond what is necessary—the minimum 4-week interval for adolescents aged ≥13 years should be respected, but longer intervals are acceptable. 1

  • Do not use MMRV vaccine in this age group—only single-antigen varicella vaccine is licensed for persons aged ≥13 years. 1

  • Do not assume that one dose provides adequate protection—breakthrough infections continue to occur and vaccinated persons with breakthrough disease remain contagious and able to sustain transmission. 3

  • Ensure proper documentation of vaccination dates—only doses with written documentation should be considered valid. 6

Implementation Strategy

The 11-12 year well-child visit should serve as an immunization visit to evaluate vaccination status and administer necessary vaccinations, including catch-up varicella vaccination for those who have received only one dose. 1

  • Physicians should use routine visits to ensure that all children without evidence of varicella immunity have received 2 doses of varicella vaccine. 1

  • From 2007 to 2014, varicella vaccination coverage with 2 or more doses increased from 8.3% to 66.9% in 13-15 year-olds, demonstrating successful implementation of catch-up campaigns, though missed vaccination opportunities persist. 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Effectiveness of 2 doses of varicella vaccine in children.

The Journal of infectious diseases, 2011

Guideline

Treatment of Chickenpox in Teenagers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

MMR and Varicella Vaccine Administration Timing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Varicella Vaccination Among US Adolescents: Coverage and Missed Opportunities, 2007-2014.

Journal of public health management and practice : JPHMP, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.